Emergent dolutegravir resistance in integrase-naïve, treatment experienced patients from Zimbabwe
We report two cases of dolutegravir (DTG) resistance in highly treatment experienced patients. Monitoring for treatment failure and adherence support is important in highly treatment experienced patients taking DTG. What this study adds: Dolutegravir is the mainstay of HIV treatment programmes and...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
AOSIS
2022-10-01
|
Series: | Southern African Journal of HIV Medicine |
Subjects: | |
Online Access: | https://sajhivmed.org.za/index.php/hivmed/article/view/1435 |